Research ArticleClinical Investigations
Baseline 18F-FDG PET/CT Parameters as Imaging Biomarkers of Overall Survival in Castrate-Resistant Metastatic Prostate Cancer
Hossein Jadvar, Bhushan Desai, Lingyun Ji, Peter S. Conti, Tanya B. Dorff, Susan G. Groshen, Jacek K. Pinski and David I. Quinn
Journal of Nuclear Medicine August 2013, 54 (8) 1195-1201; DOI: https://doi.org/10.2967/jnumed.112.114116
Hossein Jadvar
1Division of Nuclear Medicine, Department of Radiology, Keck School of Medicine of USC, University of Southern California, Los Angeles, California; and
Bhushan Desai
1Division of Nuclear Medicine, Department of Radiology, Keck School of Medicine of USC, University of Southern California, Los Angeles, California; and
Lingyun Ji
2Division of Cancer Medicine, Department of Medicine, Kenneth J. Norris Jr. Comprehensive Cancer Center, Keck School of Medicine of USC, University of Southern California, Los Angeles, California
Peter S. Conti
1Division of Nuclear Medicine, Department of Radiology, Keck School of Medicine of USC, University of Southern California, Los Angeles, California; and
Tanya B. Dorff
2Division of Cancer Medicine, Department of Medicine, Kenneth J. Norris Jr. Comprehensive Cancer Center, Keck School of Medicine of USC, University of Southern California, Los Angeles, California
Susan G. Groshen
2Division of Cancer Medicine, Department of Medicine, Kenneth J. Norris Jr. Comprehensive Cancer Center, Keck School of Medicine of USC, University of Southern California, Los Angeles, California
Jacek K. Pinski
2Division of Cancer Medicine, Department of Medicine, Kenneth J. Norris Jr. Comprehensive Cancer Center, Keck School of Medicine of USC, University of Southern California, Los Angeles, California
David I. Quinn
2Division of Cancer Medicine, Department of Medicine, Kenneth J. Norris Jr. Comprehensive Cancer Center, Keck School of Medicine of USC, University of Southern California, Los Angeles, California

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 54, Issue 8
August 1, 2013
Baseline 18F-FDG PET/CT Parameters as Imaging Biomarkers of Overall Survival in Castrate-Resistant Metastatic Prostate Cancer
Hossein Jadvar, Bhushan Desai, Lingyun Ji, Peter S. Conti, Tanya B. Dorff, Susan G. Groshen, Jacek K. Pinski, David I. Quinn
Journal of Nuclear Medicine Aug 2013, 54 (8) 1195-1201; DOI: 10.2967/jnumed.112.114116
Baseline 18F-FDG PET/CT Parameters as Imaging Biomarkers of Overall Survival in Castrate-Resistant Metastatic Prostate Cancer
Hossein Jadvar, Bhushan Desai, Lingyun Ji, Peter S. Conti, Tanya B. Dorff, Susan G. Groshen, Jacek K. Pinski, David I. Quinn
Journal of Nuclear Medicine Aug 2013, 54 (8) 1195-1201; DOI: 10.2967/jnumed.112.114116
Jump to section
Related Articles
Cited By...
- Intrapatient Intermetastatic Heterogeneity Determined by Triple-Tracer PET Imaging in mCRPC Patients and Correlation to Survival: The 3TMPO Cohort Study
- A Comparison of 18F-DCFPyL, 18F-NaF, and 18F-FDG PET/CT in a Prospective Cohort of Men with Metastatic Prostate Cancer
- Quantification of Metastatic Prostate Cancer Whole-Body Tumor Burden with 18F-FDG PET Parameters and Associations with Overall Survival After First-Line Abiraterone or Enzalutamide: A Single-Center Retrospective Cohort Study
- Appropriate Use Criteria for Imaging Evaluation of Biochemical Recurrence of Prostate Cancer After Definitive Primary Treatment
- Prediction of Time to Hormonal Treatment Failure in Metastatic Castration-Sensitive Prostate Cancer with 18F-FDG PET/CT
- PET of Glucose Metabolism and Cellular Proliferation in Prostate Cancer
- What Medical, Urologic, and Radiation Oncologists Want from Molecular Imaging of Prostate Cancer
- A Phase I/II Study for Analytic Validation of 89Zr-J591 ImmunoPET as a Molecular Imaging Agent for Metastatic Prostate Cancer
- PET/MR Imaging: A Critical Appraisal
- Stand Up to Cancer Phase Ib Study of Pan-Phosphoinositide-3-Kinase Inhibitor Buparlisib With Letrozole in Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer
- Molecular Imaging of Prostate Cancer with PET